- Unaudited Full Year Trading Update
- Appointment of new Chief Financial Officer
- Q3 2023 U.S. Commercial Highlights
- PDMR Transaction Notification
- Abstract to be presented at Healthcare Conference
- Chief Financial Officer Transition
- Result of REX Retail Offer
- Block listing Interim Return
- Completion of SWK Financing
- Successful completion of US$6.1m Equity Fundraise
More ▼
Key statistics
On Thursday, Shield Therapeutics PLC (STX:LSE) closed at 2.03, 6.58% above its 52-week low of 1.90, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.00 |
---|---|
High | 1.92 |
Low | 1.92 |
Bid | 1.90 |
Offer | 2.20 |
Previous close | 2.00 |
Average volume | 1.58m |
---|---|
Shares outstanding | 782.06m |
Free float | 342.06m |
P/E (TTM) | -- |
Market cap | 15.84m GBP |
EPS (TTM) | -0.1549 GBP |
Data delayed at least 20 minutes, as of Mar 28 2024 16:22 BST.
More ▼
Investors Chronicle View
The last IC recommendation on Shield Therapeutics PLC shares was Hold at 155.00 on 08 Aug 2019Read the full article